--Vistide, 75MG/ML 5ML Vial

The U.S. Army Medical Research Acquisition Activity intends to negotiate a firm fixed-price contract with Gliead Sciences, Foster City CA. The requirement entails a supply of FDA licensed drug product Vistide, 75mg/ml, 5mL single use vial (NSN61958-0101-01). We are requesting to purchase 48 vials. This contract shall be issued using other than full and open competition procedures in accordance with FAR 6.302-1(a)(2). Gilead is uniquely qualified to provide this product because Gilead is the only manufacturer of this injectible pharmaceutical. There are no other resources. This is not a request for competitive proposals but parties purporting to have the requisite credentials to supply Vistide must finish in writing, factual information, which clearly supports and demonstrates evidence of such abilities. This information must be faxed to Abigail Diffenderfer (301) 619-3500 by 27 March 2009 NLT 1600 hrs ET. A determination by the Contracting Officer not to compete this proposed action based on any responses from this notice is solely within the discretion of the Contracting Officer.